TY - JOUR
T1 - Varicella zoster virus productively infects human natural killer cells and manipulates phenotype
AU - Campbell, Tessa Mollie
AU - McSharry, Brian Patrick
AU - Steain, Megan
AU - Ashhurst, Thomas Myles
AU - Slobedman, Barry
AU - Abendroth, Allison
N1 - Publisher Copyright:
© 2018 Campbell et al.
PY - 2018/4/30
Y1 - 2018/4/30
N2 - Varicella zoster virus (VZV) is a ubiquitous human alphaherpesvirus, responsible for varicella upon primary infection and herpes zoster following reactivation from latency. To establish lifelong infection, VZV employs strategies to evade and manipulate the immune system to its advantage in disseminating virus. As innate lymphocytes, natural killer (NK) cells are part of the early immune response to infection, and have been implicated in controlling VZV infection in patients. Understanding of how VZV directly interacts with NK cells, however, has not been investigated in detail. In this study, we provide the first evidence that VZV is capable of infecting human NK cells from peripheral blood in vitro. VZV infection of NK cells is productive, supporting the full kinetic cascade of viral gene expression and producing new infectious virus which was transmitted to epithelial cells in culture. We determined by flow cytometry that NK cell infection with VZV was not only preferential for the mature CD56dimNK cell subset, but also drove acquisition of the terminally-differentiated maturity marker CD57. Interpretation of high dimensional flow cytometry data with tSNE analysis revealed that culture of NK cells with VZV also induced a potent loss of expression of the low-affinity IgG Fc receptor CD16 on the cell surface. Notably, VZV infection of NK cells upregulated surface expression of chemokine receptors associated with trafficking to the skin –a crucial site in VZV disease where highly infectious lesions develop. We demonstrate that VZV actively manipulates the NK cell phenotype through productive infection, and propose a potential role for NK cells in VZV pathogenesis.
AB - Varicella zoster virus (VZV) is a ubiquitous human alphaherpesvirus, responsible for varicella upon primary infection and herpes zoster following reactivation from latency. To establish lifelong infection, VZV employs strategies to evade and manipulate the immune system to its advantage in disseminating virus. As innate lymphocytes, natural killer (NK) cells are part of the early immune response to infection, and have been implicated in controlling VZV infection in patients. Understanding of how VZV directly interacts with NK cells, however, has not been investigated in detail. In this study, we provide the first evidence that VZV is capable of infecting human NK cells from peripheral blood in vitro. VZV infection of NK cells is productive, supporting the full kinetic cascade of viral gene expression and producing new infectious virus which was transmitted to epithelial cells in culture. We determined by flow cytometry that NK cell infection with VZV was not only preferential for the mature CD56dimNK cell subset, but also drove acquisition of the terminally-differentiated maturity marker CD57. Interpretation of high dimensional flow cytometry data with tSNE analysis revealed that culture of NK cells with VZV also induced a potent loss of expression of the low-affinity IgG Fc receptor CD16 on the cell surface. Notably, VZV infection of NK cells upregulated surface expression of chemokine receptors associated with trafficking to the skin –a crucial site in VZV disease where highly infectious lesions develop. We demonstrate that VZV actively manipulates the NK cell phenotype through productive infection, and propose a potential role for NK cells in VZV pathogenesis.
KW - CD57 Antigens/metabolism
KW - Herpesvirus 3, Human/pathogenicity
KW - Humans
KW - Killer Cells, Natural/immunology
KW - Phenotype
KW - Skin/immunology
KW - T-Lymphocytes/immunology
KW - Varicella Zoster Virus Infection/immunology
KW - Virus Latency
KW - Virus Replication
UR - http://www.scopus.com/inward/record.url?scp=85046420601&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046420601&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1006999
DO - 10.1371/journal.ppat.1006999
M3 - Article
C2 - 29709039
AN - SCOPUS:85046420601
SN - 1553-7366
VL - 14
SP - 1
EP - 25
JO - PLoS Pathogens
JF - PLoS Pathogens
IS - 4
M1 - e1006999
ER -